Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Francesc X SorianoG E Hardingham

Abstract

Neuroprotection can be induced by low doses of NMDA, which activate both synaptic and extrasynaptic NMDA receptors. This is in apparent contradiction with our recent findings that extrasynaptic NMDA receptor signaling exerts a dominant inhibitory effect on prosurvival signaling from synaptic NMDA receptors. Here we report that exposure to low preconditioning doses of NMDA results in preferential activation of synaptic NMDA receptors because of a dramatic increase in action potential firing. Both acute and long-lasting phases of neuroprotection in the face of apoptotic or excitotoxic insults are dependent on this firing enhancement. Key mediators of synaptic NMDA receptor-dependent neuroprotection, phosphatidylinositol 3 kinase-Akt (PI3 kinase-Akt) signaling to Forkhead box subgroup O (FOXO) export and glycogen synthase kinase 3beta (GSK3beta) inhibition and cAMP response element-binding protein-dependent (CREB-dependent) activation of brain-derived neurotrophic factor (BDNF), can be induced only by low doses of NMDA via this action potential-dependent route. In contrast, NMDA doses on the other side of the toxicity threshold do not favor synaptic NMDA receptor activation because they strongly suppress firing rates below baselin...Continue Reading

References

Jul 1, 1989·Trends in Neurosciences·S A Lipton, S B Kater
Oct 10, 1995·Proceedings of the National Academy of Sciences of the United States of America·L L BambrickB K Krueger
Mar 23, 1999·Nature Medicine·S A Lipton, N Nakanishi
Apr 10, 1999·Nature Neuroscience·A K StoutI J Reynolds
Sep 30, 1999·Microscopy Research and Technique·G E Hardingham, H Bading
Feb 1, 2000·Trends in Neurosciences·M R Walton, I Dragunow
Oct 31, 2000·The Journal of Biological Chemistry·A YamaguchiM Tohyama
Nov 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·C IkonomidouL Turski
Apr 27, 2001·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·S YanoY Ushio
May 3, 2001·The Journal of Biological Chemistry·T J CollinsM D Bootman
Aug 3, 2001·Nature Reviews. Molecular Cell Biology·B Mayr, M Montminy
Jul 26, 2002·Archives of Biochemistry and Biophysics·Karen C Arden, William H Biggs
Aug 13, 2002·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Takayuki KawanoKohji Fukunaga
Oct 31, 2002·The European Journal of Neuroscience·Barbara MontiAntonio Contestabile
Nov 26, 2002·Biochimica Et Biophysica Acta·Giles E Hardingham, Hilmar Bading
Jan 22, 2003·The Biochemical Journal·Jenny BainPhilip Cohen
Jan 22, 2003·Trends in Neurosciences·Giles E Hardingham, Hilmar Bading
May 13, 2003·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Roberto Malinow

❮ Previous
Next ❯

Citations

Apr 23, 2013·Neuroscience Bulletin·Xiao-Min Zhang, Jian-Hong Luo
Jul 21, 2009·Acta Pharmacologica Sinica·Xiao-qian LiuZheng-hong Qin
Dec 19, 2008·Nature·Rujun KangAlaa El-Husseini
Mar 18, 2008·Nature Neuroscience·Sofia PapadiaGiles E Hardingham
Sep 16, 2010·Nature Reviews. Neuroscience·Giles E Hardingham, Hilmar Bading
Jul 20, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gang LeiKenneth M Johnson
Feb 2, 2012·The Journal of Biological Chemistry·Bruna Barneda-ZahoneroJosé Rodríguez-Alvarez
Oct 11, 2008·The Journal of Biological Chemistry·Joseph S TauskelaGeoffrey A R Mealing
Oct 30, 2007·Cerebral Cortex·Nicolas HeckHeiko J Luhmann
Oct 23, 2010·Cerebral Cortex·Antje GolbsHeiko J Luhmann
Mar 11, 2008·Epilepsia·Matthew Walker
Jun 3, 2010·The Journal of Clinical Investigation·Sika ZhengValina L Dawson
May 5, 2010·The Journal of Clinical Investigation·Ramiro EcheverryManuel Yepes
Nov 15, 2007·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Sofia Papadia, Giles E Hardingham
Jul 11, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Golo KronenbergMatthias Endres
Oct 24, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Julie A HarrisEdwin W Rubel
Oct 1, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·David T Stark, Nicolas G Bazan
Feb 19, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Frédéric LéveilléGiles E Hardingham
May 11, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Christine M WrogeSteven Mennerick
Apr 2, 2010·Oxidative Medicine and Cellular Longevity·Frédéric LéveilléGiles E Hardingham
Nov 2, 2006·Proceedings of the National Academy of Sciences of the United States of America·Juan Carlos de Rivero VaccariRoderick A Corriveau
Oct 4, 2014·Neurochemistry International·Carol E VásquezGabrielle B Britton
Nov 29, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yubin WangMichel Baudry
May 29, 2015·International Journal of Molecular Sciences·Cesar ReisJohn H Zhang
Apr 25, 2008·Critical Reviews in Toxicology·Edward J Calabrese
Apr 25, 2008·Critical Reviews in Toxicology·Edward J Calabrese
Jan 13, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Edward J Calabrese
Feb 13, 2016·Neuropharmacology·Joseph S TauskelaNicolas Blondeau
Dec 30, 2014·Biochimica Et Biophysica Acta·Philip HaselGiles E Hardingham
Jan 10, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Edward J Calabrese
Jan 11, 2012·Neuroscience and Biobehavioral Reviews·Charles F Zorumski, Yukitoshi Izumi

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.